21 CFR 640.11
§ 640.11 General requirements.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 640.11, § 640.11 General requirements, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/88469
- Permanent ID
ys:prov:88469@1- SHA-256
746e137d4e85a561d903e97d93ce7cce89ffe816b0006930115eeefe57153874
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Storage. Immediately after processing, the Red Blood Cells shall be placed in storage and maintained at a temperature between 1 and 6 °C.
(b) Inspection. The product shall be inspected immediately after separation of the plasma, periodically during storage, and at the time of issue. The product shall not be issued if there is any abnormality in color or physical appearance or if there is any indication of microbial contamination.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.